Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and Appointment of Fred Hassan as Chair
GlobeNewswire · 财报与经营业绩 · November 2, 2026 at 4:30 PM ET
Read the full report at the original publisher.